“France Cancels order of Merck covid drug on efficacy fears”
There really is very little competition in the covid antiviral space. (approved) Not everyone is going to be able to take the Pfizer drug if they can even get hold of it. FDA will want more options.
- Forums
- ASX - By Stock
- Ann: Update on Biotron HIV-1 And COVID-19 Programs
“France Cancels order of Merck covid drug on efficacy...
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $17.59M |
Open | High | Low | Value | Volume |
1.9¢ | 2.0¢ | 1.9¢ | $11.54K | 604.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1466986 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 830622 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1466986 | 0.019 |
11 | 2301165 | 0.018 |
5 | 688000 | 0.017 |
11 | 1524350 | 0.016 |
4 | 660000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 830622 | 7 |
0.021 | 168000 | 2 |
0.022 | 600000 | 2 |
0.023 | 323000 | 3 |
0.024 | 255035 | 3 |
Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online